T Jandlová

Czech Academy of Sciences — Czech Republic

Immunology and Microbiology · Life Sciences

10h-index470citations51works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(28), Virus-based gene therapy research(15), Cancer Research and Treatments(11), Monoclonal and Polyclonal Antibodies Research(9), Immune Cell Function and Interaction(8)

Publications51 total

Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Folia Biologica·2005· 6 citedOpen Access
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
Folia Biologica·2004· 16 citedOpen Access
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
Folia Biologica·2004· 7 citedOpen Access
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours
International Journal of Oncology·2003· 17 cited
Local IFN-gamma therapy of HPV16-associated tumours.
PubMed·2003· 4 cited
MHC Class I+ and Class I- HPV16-Associated Tumours Expressing the E7 Oncoprotein Do Not Cross-react in Immunization/Challenge Experiments
Folia Biologica·2003· 4 citedOpen Access
Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors
Folia Biologica·2003· 9 citedOpen Access
Immunotherapy of HPV 16-Associated Tumours with Tumour Cell Line/Dendritic Cell Line (TC-1/DC2.4) Hybrid Vaccines
Folia Biologica·2003· 3 citedOpen Access
Local IFN-γ Therapy of HPV16-Associated Tumours
Folia Biologica·2003Open Access
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin
International Journal of Oncology·2002· 12 cited
Tumour-Inhibitory Effects of Dendritic Cells Administered at the Site of HPV 16-Induced Neoplasms
Folia Biologica·2002· 7 citedOpen Access
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
Oncology Reports·2001· 4 cited
Peritumoral Administration of Antigen-Unstimulated Bone Marrow-Derived Dendritic Cells Inhibits Tumour Growth
Folia Biologica·2000· 15 citedOpen Access
Intratumoral IL-2 Gene Transfer Improves the Therapeutic Efficacy of IL-12 but Not IL-18
Folia Biologica·2000· 2 citedOpen Access
Irradiation of Genetically Modified Plasmacytoma Vaccines Results in Upregulation of CD80 Molecule Expression, IL-2 Production and Higher Therapeutic Efficacy of the Vaccines
Folia Biologica·2000· 2 citedOpen Access
CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice.
Oncology Reports·1999
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
International Journal of Oncology·1999· 38 cited
Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.
PubMed·1999· 4 cited
IL-2 gene-modified tumour vaccines: monitoring of IL-2 levels in serum and peritoneal cavity of vaccinated mice.
PubMed·1999· 1 cited
Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines.
PubMed·1999· 4 cited
page 1 of 3Next →

Frequent Co-authors

J Bubeník(45), Jana Šímová(34), M Indrová(23), Jana Bieblová(11), D Bubeníková(9), V. Vonka(9), Romana Mikyšková(8), Michal Šmahel(6), J. Kieler(5), Luis Mendoza(5), Pavel Rössner(5), R Hájková(4), V Sobota(4), Milan Reiniš(4), J Zeuthen(4), Miroslav Malkovský(4), Jan Bubeník(3), C Radzikowski(3), E Suhajová(3), Peter Perlmann(2)